Clinical Outcome Measures
Cross-source consensus on Clinical Outcome Measures from 1 sources and 5 claims.
1 sources · 5 claims
Other
Highlighted claims
- Atopic dermatitis is considered uncontrolled when the ADCT score is at least 7, when a response falls in a shaded scoring area, or when the score increases by at least 5 points. — Applying medical hypnosis in the management of atopic dermatitis in children and young adolescents: study protocol for a pilot cluster randomised controlled trial (Hypno-AD)
- PO-SCORAD ranges from 0 to 103 and categorises disease as mild below 25, moderate above 25 and below 50, and severe above 50. — Applying medical hypnosis in the management of atopic dermatitis in children and young adolescents: study protocol for a pilot cluster randomised controlled trial (Hypno-AD)
- The Atopic Dermatitis Control Tool measures symptom severity, discomfort, sleep impact, daily activity effects, and mood or emotion effects over the previous 7 days. — Applying medical hypnosis in the management of atopic dermatitis in children and young adolescents: study protocol for a pilot cluster randomised controlled trial (Hypno-AD)
- The Patient-Oriented SCORAD evaluates eczema extent, skin dryness, inflammatory signs, itching, and sleep disorders over 2 days. — Applying medical hypnosis in the management of atopic dermatitis in children and young adolescents: study protocol for a pilot cluster randomised controlled trial (Hypno-AD)
- Exploratory clinical comparisons assess disease control and severity at 1, 3, and 6 months. — Applying medical hypnosis in the management of atopic dermatitis in children and young adolescents: study protocol for a pilot cluster randomised controlled trial (Hypno-AD)